Home

Johnson & Johnson (JNJ)

178.93
+0.09 (0.05%)
NYSE · Last Trade: Aug 21st, 11:15 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
3 Stable Dividend-Paying Stocks That Are Perfect for Retireesfool.com
Names you've heard of with track records to love.
Via The Motley Fool · August 21, 2025
9 Analysts Have This To Say About Johnson & Johnsonbenzinga.com
Via Benzinga · August 21, 2025
How Do Investors Really Feel About Johnson & Johnson?benzinga.com
Via Benzinga · August 21, 2025
Congressional Trading Report: Rep. Thomas Kean Sold Over $31K In Johnson & Johnson Stockbenzinga.com
Via Benzinga · August 21, 2025
This Pharma Giant Is Set To Invest $2B To Expand Manufacturing In North Carolina, And It Just Received A Price Target Hike From Citi: Do You Own It?stocktwits.com
Via Stocktwits · August 21, 2025
Sender Buys Into the Turnaround Story at Kenvuefool.com
Via The Motley Fool · August 21, 2025
Market's Muted Ascent: A Cautious Calm Near Record Highs
Despite hovering at or near all-time highs, the major U.S. stock indices—the Dow Jones Industrial Average, S&P 500, and Nasdaq Composite—have recently displayed a remarkably subdued daily performance. This period of consolidation, marked by narrow trading ranges and fractional movements, signals a market grappling with a
Via MarketMinute · August 19, 2025
The Unsettling U: U.S. Treasury Yield Curve Signals Market Standoff and Economic Crossroads
The U.S. Treasury yield curve has contorted into a rare and unsettling U-shape, a configuration seen in only a fraction of the past five decades. This unusual curve, characterized by high short-term rates, a distinct dip in intermediate-term yields, and a subsequent rise for longer maturities, signals a profound
Via MarketMinute · August 19, 2025
Wall Street Holds Its Breath: Awaiting Powell's Verdict Amidst Pervasive Caution
Wall Street is currently gripped by a palpable "wait-and-see" sentiment, as investors adopt an overwhelmingly cautious stance ahead of Federal Reserve Chair Jerome Powell's highly anticipated speech at the Jackson Hole Symposium. This pervasive mood has led to muted trading activity across major indices, reflecting a deep-seated reluctance among market
Via MarketMinute · August 19, 2025
Carlsmed's Personalized Spine Implants Get Significant Reimbursement Advantagebenzinga.com
Carlsmed secures NTAP reimbursement and FDA support, while BofA projects strong revenue growth and assigns a Buy rating with a $16 target.
Via Benzinga · August 18, 2025
10 Health Care Stocks With Whale Alerts In Today's Sessionbenzinga.com
Via Benzinga · August 18, 2025
Economic Barometer: Consumer Spending and Labor Market Trends Under Scrutiny
The global financial landscape is currently navigating a period of heightened uncertainty, with key economic indicators signaling a notable deceleration in private consumption and emerging fragilities within the labor market. These intertwined trends are casting a long shadow over the stock market, prompting investors to re-evaluate their positions and brace
Via MarketMinute · August 18, 2025
Massive Headwinds Are on the Horizon for Pharmaceutical Stocks, but Here Are 2 That Could Weather the Stormfool.com
These companies have successfully navigated similar obstacles before.
Via The Motley Fool · August 17, 2025
These Are the 3 Smartest Dividend Stocks Todayfool.com
These three dividend stocks offer steady income and a history of delivering through thick and thin.
Via The Motley Fool · August 16, 2025
Federal Reserve Rate Cut Hopes Dwindle as Stubborn Inflation Surges Post-PPI
Washington D.C. – Hopes for an imminent Federal Reserve interest rate cut have significantly dimmed following the release of hotter-than-expected Producer Price Index (PPI) data on August 14, 2025. The July PPI report revealed a surprising surge in wholesale inflation, forcing traders and economists to reconsider the widespread expectation of
Via MarketMinute · August 14, 2025
Sector Rotation in Full Swing: Cyclical Stocks Gain Favor as Investors Shift from Tech
The financial markets are currently experiencing a significant sector rotation, as investors increasingly shift their capital from growth-oriented technology stocks towards more value-driven cyclical sectors. This strategic reallocation of assets reflects a broader recalibration of market expectations, signaling a potential late-stage economic cycle or an environment characterized by persistent inflation.
Via MarketMinute · August 14, 2025
Treasury Yields and Dollar Climb as Inflation Report Shifts Market Dynamics
The financial markets are once again grappling with the persistent specter of inflation, as the latest reports have sent ripples through the bond market and currency exchange rates. Following a series of economic data releases, the yield on the benchmark 10-year Treasury note has seen a notable climb, while the
Via MarketMinute · August 14, 2025
U.S. Economy Shows Resilience with Q2 GDP Growth, But Labor Market Cools
The United States economy presented a complex and somewhat contradictory picture in the second quarter of 2025, demonstrating a robust 3.0% annualized Gross Domestic Product (GDP) growth, a significant rebound from the previous quarter's contraction. This headline figure suggests a resilient economy, defying some predictions of an imminent slowdown.
Via MarketMinute · August 14, 2025
Palantir Is Now the 19th Largest Public Company. Is This House of Cards About to Come Crashing Down?fool.com
Palantir Technologies is priced for perfection. Unfortunately, no situation on Wall Street is ever perfect.
Via The Motley Fool · August 14, 2025
Fed Watch: September Rate Cut Now 96% Likely After Favorable Inflation Data
The financial markets are abuzz with heightened expectations for a Federal Reserve interest rate cut in September, with probabilities soaring to an overwhelming 96%. This dramatic shift in sentiment comes on the heels of recent inflation data, particularly the July Consumer Price Index (CPI) report, which has largely been interpreted
Via MarketMinute · August 13, 2025
Vor Bio Rallies On Strong Data For Autoimmune Drug Candidatebenzinga.com
Vor Bio shares climb as RemeGen's Phase 3 study in China shows telitacicept improves disease activity in primary Sjögren's disease.
Via Benzinga · August 13, 2025
If You're In Your 20's, Consider Buying These 3 Healthcare Stocksfool.com
If you have decades to go before you retire, you want to make sure you own companies that know how to survive and thrive.
Via The Motley Fool · August 13, 2025
Johnson & Johnson EVP Sells JNJ Shares Worth $3 Millionfool.com
Via The Motley Fool · August 12, 2025
Got $1,000? 3 Dividend Stocks to Buy and Hold Foreverfool.com
Dip into a beaten-down market sector for deals on some proven winners.
Via The Motley Fool · August 12, 2025
The Specter of Stagflation: Trump's Tariffs Cast a Long Shadow Over the U.S. Economy
Economists and investors are increasingly sounding the alarm over the growing risk of "stagflation," a perilous economic phenomenon characterized by high inflation coupled with stagnant economic growth. At the heart of these concerns are the tariff policies enacted by former President Donald Trump, which many experts fear could simultaneously drive
Via MarketMinute · August 11, 2025